How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends?
Key PointsAmgen, Pfizer, J&J, AbbVie, and Bristol Myers Squibb are all pharmaceutical companies that pay quarterly dividends.
Dividend investors frequently prioritize yield, which can result in an overly aggressive portfolio. In the pharmaceutical industry, Pfizer (NYSE: PFE) offers an appealing 6.1% yield. To generate over $12,000 annually in dividends, or roughly $1,000 monthly income, an investment of approximately $200,000 in the stock would be necessary.
However, concentrating all investments in a single stock poses significant risks. Pfizer faces several drugs with impending patent expirations, and its research and development endeavors have yet to yield new drugs to replace the income they generate. Furthermore, although its cash flow can cover the dividend, earnings do not. A more prudent approach may involve investing roughly $70,000 in each of the following five pharmaceutical stocks: Pfizer (NYSE: PFE), Johnson & Johnson (NYSE: JNJ), AbbVie (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Amgen (NASDAQ: AMGN). Here is a detailed examination of each company.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
